Toenail Onychomycosis in a Portuguese Geriatric Population

Mycopathologia

Volumn 172, Issue 1, 2011, Pages 55-61

  Dias, N ^a,b   Santos, C ^a   Portela, M ^b   Lima, N ^a  

^a UNIVERSITY OF MINHO   (Portugal)

^b Centro de Investigação em Tecnologias da Saúde CITS   (Portugal)

Author keywords

Dermatophyte; Geriatrics; Onychomycosis

Indexed keywords

AGED; ARTICLE; CLASSIFICATION; FEMALE; FUNGUS; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; NAIL; ONYCHOMYCOSIS; PATHOLOGY; PORTUGAL; RISK FACTOR;

AGED; AGED, 80 AND OVER; FEMALE; FUNGI; HUMANS; MALE; MIDDLE AGED; NAILS; ONYCHOMYCOSIS; PORTUGAL; RISK FACTORS;

ARTHRODERMA BENHAMIAE; ARTHRODERMATACEAE; BACTERIA (MICROORGANISMS); FUSARIUM; SCOPULARIOPSIS; TRICHOPHYTON INTERDIGITALE; TRICHOPHYTON RUBRUM;

EID: 79960586043     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-011-9402-1     Document Type: Article

References (31)

1. Midgley G, Moore MK. Onychomycosis. Rev Iberoam Micol. 1998; 15: 113-7.
2. Roberts DT. Prevalence of dermatophyte onychomycosis in the United Kingdom: results of an omnibus survey. Br J Dermatol. 1992; 126((S39)): 23-7.
3. Perea S, Ramos MJ, Garau M, Gonzalez A, Noriega AR, del Palacio A. Prevalence and risk factors of tinea unguium and tinea pedis in the general population in Spain. J Clin Microbiol. 2000; 38: 3226-30.
4. Sigurgeirsson B, Steingrímsson O, Sveinsdóttir S. Prevalence of onychomycosis in Iceland: a population-based study. Acta Derm Venereol. 2002; 82: 467-9.
5. Burzykowski T, Molenberghs G, Abeck D, Haneke E, Hay R, Katsambas A, et al. High prevalence of foot diseases in Europe: results of the Achilles Project. Mycoses. 2003; 46: 496-500.
6. Elewski BE. Onychomycosis: pathogenesis, diagnosis and management. Clin Microbiol Rev. 1998; 11: 415-29.
7. Tosti A, Hay R, Arenas-Guzmán R. Patients at risk of onychomycosis: risk factor identification and active prevention. Eur Acad Dermatol Venereol. 2005; 19((S1)): 13-6.
8. Jaffe R. Onychomycosis: recognition, diagnosis, and management. Arch Fam Med. 1998; 7: 587-92.
9. Torres-Rodríguez JM, López-Jodra O. Epidemiology of nail infection due to keratinophilic fungi. Rev Iberoam Micol. 2000; 17: 1-12.
10. Drake LA, Scher RK, Smith EB, Faich GA, Smith SL, Hong JJ, et al. Effect of onychomycosis on quality of life. J Am Acad Dermatol. 1998; 38: 702-4.
11. Drake LA, Patrick DL, Fleckman P, André J, Baran R, Haneke E, et al. The impact of onychomycosis on quality of life: development of an international onychomycosis-specific questionnaire to measure patient quality of life. J Am Acad Dermatol. 1999; 41: 189-96.
12. Lubeck DP. Measuring health-related quality of life in onychomycosis. J Am Acad Dermatol. 1998; 38((Part3)): S64-6.
13. Mayser P, Freund V, Budihardja D. Toenail onychomycosis in diabetic patients: issues and management. Am J Clin Dermatol. 2009; 10: 211-20.
14. Rich P. Onychomycosis and tinea pedis in patients with diabetes. J Am Acad Dermatol. 2000; 43: S130-4.
15. Scher RK, Tavakkol A, Sigurgeirsson B, Hay RJ, Joseph WS, Tosti A, et al. Onichomycosis: diagnosis and definition of cure. J Am Acad Dermatol. 2007; 56: 939-44.
16. de Berker D. Fungal nail disease. N Engl J Med. 2009; 360: 2108-16.
17. Baran R, Hay RJ, Tosti A, Haneke E. A new classification of onychomycosis. Br J Dermatol. 1998; 139: 567-77.
18. de Araújo AJG, Bastos OM, Souza MAJ, Oliveira JC. Ocorrência de onicomicose em pacientes atendidos em consultórios dermatológicos da cidade do Rio de Janeiro, Brasil. Ann Bras Dermatol. 2003; 78: 299-308.
19. Szepietowski JC, Reich A, Garlowska E, Kulig M, Baran E. Factors influencing coexistence of toenail onychomycosis with tinea pedis and other dermatomycoses. Arch Dermatol. 2006; 142: 1279-84.
20. Saunte DM, Holgersen JB, Haedersdal M, Strauss G, Bitsch M, Svendsen OL, et al. Prevalence of toe nail onychomycosis in diabetic patients. Acta Derm Venereol. 2006; 86: 425-8.
21. Robert R, Pihet M. Conventional methods for the diagnosis of dermatophytosis. Mycopathologia. 2008; 166: 295-306.
22. Feuillade de Chauvin M. New diagnostic techniques. Eur Acad Dermatol Venereol. 2005; 19((S1)): 20-4.
23. Hay R. Literature review. Eur Acad Dermatol Venereol. 2005; 19((S1)): 1-7.
24. Roberts DT, Taylor WD, Boyle J. Guidelines for treatment of onychomycosis. Br J Dermatol. 2003; 148: 402-10.
25. Effendy I, Lecha M, Feuilhade de Chauvin M, Di Chiacchio N, Baran R. Epidemiology and clinical classification of onychomycosis. J Eur Acad Dermatol Venereol. 2005; 19((S1)): 8-12.
26. Seebacher C, Brasch J, Abeck D, Cornely O, Effendy I, Ginter-Hanselmayer G, et al. Onychomychosis. Mycoses. 2007; 50: 321-7.
27. Seebacher C, Bouchara JP, Mignon B. Updates on the epidemiology of dermatophyte infections. Mycopathologia. 2008; 166: 335-52.
28. Valdigen GL, Pereira T, Macedo C, Duarte ML, Oliveira P, Ludovico P, et al. A twenty-year survey of dermatophytosis in Braga, Portugal. Int J Dermatol. 2006; 45: 822-7.
29. English MP. Nails and fungi. Br J Dermatol. 1976; 94: 697-701.
30. Arrese JE, Piérard-Franchimont C, Piérard GE. Facing up to the diagnostic uncertainty and management of onychomycoses. Int J Dermatol. 1999; 38((S2)): 1-6.
31. Summerbell RC, Cooper E, Bunn U, Jamieson F, Gupta AK. Onychomycosis: a critical study of techniques and criteria for confirming the etiologic significance of nondermatophytes. Med Mycol. 2005; 43: 39-59.